Shelter Pharma Qualifies Technically for Veterinary Medicine Supply Tender from Verka Dairies

Shelter Pharma Qualifies Technically for Veterinary Medicine Supply Tender from Verka Dairies

Shelter Pharma Qualifies Technically for Veterinary Medicine Supply Tender from Verka Dairies​

Shelter Pharma Ltd, a manufacturer and supplier of pharmaceutical and veterinary healthcare products, has received an intimation regarding participation in a negotiation meeting. The meeting is connected to a tender issued by Verka Dairies (Punjab State Cooperative Milk Producers' Federation Limited) for the supply of veterinary medicines.

The company confirmed that it has successfully cleared the technical evaluation stage for this tender process. This development marks a point of growing presence and credibility for Shelter Pharma in the veterinary healthcare segment.

The outcome of the negotiation meeting and any further material developments, such as the award of the contract, will be communicated in due course.

Financial and contract details related to the tender are summarized below:

ParticularsDetails
Name of the entity awarding the tenderVerka (Punjab State Cooperative Milk Producers' Federation Limited)
Nature of contractTender for supply of veterinary medicines
Stage of the contractQualified in technical evaluation; invited for negotiation meeting
Whether domestic / internationalDomestic
Significant terms & conditionsYet to be finalized
Expected time periodTo be determined post finalization
Whether promoter/promoter group has interestNo
Whether transaction falls under related party transactionsNo

Stock Price Movement​

In today's trade, Shelter Pharma Ltd shares are currently traded flat at ₹28.50. The stock is down ₹0.85, reflecting a decline from yesterday's close of ₹29.35.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top